An experiment involving 540 weanling pigs was conducted to determine the effect of the addition of Cu (5, 125, or 250 ppm) on the growth performance and serum fatty acid profiles of pigs fed diets that contained no added fat (NO FAT), 5% added soybean oil (SBO), 5% added animal fat (ANI), or 5% added medium-chain triglycerides (MCT). Pigs had ad libitum access to corn-soybean meal-based diets that contained 10% whey and 5% fish meal during the 28-d trial. Pigs were weighed and pen feed intakes were recorded weekly. Blood samples were collected for serum fatty acid analysis on d 1, 14, and 28 of the trial. The addition of all sources of fat to the diet increased (P < .001) ADG and gain:feed ratios during the 28-d trial. Increasing levels of dietary Cu linearly increased (P < .001) ADG and quadratically increased (P < .05) ADFI during the 28-d experiment. A Cu x fat source interaction was observed d 14 to 28 for ADG. The ADG of pigs fed NO FAT or SBO linearly increased with increasing levels of Cu, and pigs fed MCT or ANI had quadratic increases in ADG as Cu levels increased. Compared with the NO FAT diet, d-28 serum saturated fatty acid concentrations were decreased (P < .01) by the addition of SBO or ANI, monounsaturated fatty acid concentrations were decreased (P < .001) by the addition of SBO, and polyunsaturated fatty acid concentrations were increased by the addition of SBO (P < .001).(ABSTRACT TRUNCATED AT 250 WORDS)
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2527/1993.7182187x | DOI Listing |
Background: Alzheimer's disease (AD) is the most common cause of dementia worldwide. It is characterized by dysfunction in the U1 small nuclear ribonucleoproteins (snRNPs) complex, which may precede TAU aggregation, enhancing premature polyadenylation, spliceosome dysfunction, and causing cell cycle reentry and death. Thus, we evaluated the effects of a synthetic single-stranded cDNA, called APT20TTMG, in induced pluripotent stem cells (iPSC) derived neurons from healthy and AD donors and in the Senescence Accelerated Mouse-Prone 8 (SAMP8) model.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Keck School of Medicine at University of Southern California, Los Angeles, CA, USA.
Background: ABCA1-mediated cholesterol transport is a central feature in many lipid- dependent diseases including APOE4-associated Alzheimer's disease and atherosclerosis-CVD. ABCA1 upregulation of RNA transcription by nuclear factors (LXR, RXR) have been associated with liver side-effects because of the common promotor element for ABCA1 and Fatty Acid Synthase. The ABCA1 agonist CS6253, derived from the C-terminal of apoE was designed to stabilize and enhance ABCA1 function, thereby providing a safe alternative to transcriptional upregulation.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Georgia, College of Pharmacy, Athens, GA, USA.
Background: Reducing chronic inflammation has been linked to anti-inflammatory foods and may be implicated in treating Alzheimer's disease (AD). Plants produce antioxidants, such as phytochemicals, that appear to reduce the incidence of chronic inflammatory diseases. Phytochemicals may include active substances like polyphenols.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Georgia, College of Pharmacy, Athens, GA, USA.
Background: Lipids are key modulators in the pathogenesis of Alzheimer's disease (AD). Dysregulation of lipid homeostasis may disrupt the blood brain barrier, alter myelination, disturb cellular signaling and cause abnormal processing of the amyloid precursor protein. The purpose of this scoping review was to evaluate fatty acid supplementation in patients with AD.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Virginia, Charlottesville, VA, USA.
Background: Spousal care partners to people with dementia (PWD) have a higher rate of depression and anxiety when compared to similar age controls. Previous studies have suggested a role of gut microbiota in the pathophysiology of neuropsychiatric symptoms and Alzheimer's disease (AD). Thus, our study aims to: (1) determine the presence and severity of depression and anxiety in care partners of PWD, and (2) determine the concentrations of short chain fatty acids (SCFA), which are mainly produced by gut microbiota and are important in mediating gut microbiota effects, in the blood of care partners of PWD.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!